MedTrace Logo

Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

NCT03258294 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2017-08-23

No results posted yet for this study

Summary

This clinical study is a double-blind, randomized, placebo-controlled trial to investigate the effects of melatonin on the sleep disturbance symptoms of Parkinson's disease patients, symptoms which have a significant impact on the quality of life of these patients.

Conditions

Interventions

DRUG

Melatonin(Circadin®)

DRUG

Placebo Oral Tablet

Sponsors & Collaborators

  • Kuhnil Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • KIMJisun

    lead OTHER

Principal Investigators

  • Jisun Kim · Samsung Medical Center, Department of Neurology

  • Eungseok Oh · Chungnam National University Hospital, Department of Neurology

  • Wooyoung Jang · Gangneung Asan Hospital, Department of Neurology

  • Jinse Park · Inje University Haeundae Paik Hospital, Department of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-13
Primary Completion
2018-12-30
Completion
2018-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03258294 on ClinicalTrials.gov